Suchergebnisse - "Drug Administration Schedule"

PubPharm (145)

1

Prolonged vs intermittent intravenous infusion of β-lactam antibiotics for patients with sepsis : a systematic review of randomized clinical trials with meta-analysis and trial sequential analysis

enthalten in: Annals of intensive care | 2023

von Li, X. | Long, Y. | Wu, G. | +4

2

Prolonged vs intermittent intravenous infusion of β-lactam antibiotics for patients with sepsis: a systematic review of randomized clinical trials with meta-analysis and trial sequential analysis

enthalten in: Annals of intensive care | 2023

von Li, X. | Long, Y. | Wu, G. | +4

3

The Clinical Efficacy of Multidose Oritavancin : A Systematic Review

enthalten in: Antibiotics (Basel, Switzerland) | 2023

von Baiardi, G. | Cameran Caviglia, M. | Piras, F. | +6

4

Clinical efficacy and safety of individualized pembrolizumab administration based on pharmacokinetic in advanced non-small cell lung cancer : A prospective exploratory clinical trial

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2023

von Wang, N. | Zheng, L. | Li, M. | +5

5

Efficacy of emicizumab is maintained throughout dosing intervals for bleed prophylaxis

enthalten in: Research and practice in thrombosis and haemostasis | 2023

von Pipe, S. | Trzaskoma, B. | Minhas, M. | +7

ErratumIn: Res Pract Thromb Haemost. 2023 May 27;7(4):100191. - PMID 37538504

6

Combination Chemotherapy of Multidrug-resistant Early-stage Colon Cancer : Determining Optimal Dose Schedules by High-performance Computer Simulation

enthalten in: Cancer research communications | 2023

von Cockrell, C. | Axelrod, D.

7

The Clinical Efficacy of Multidose Oritavancin: A Systematic Review

in: Antibiotics | 2023

von Giammarco Baiardi | Michela Cameran Caviglia | Fabio Piras | +6

8

Prolonged vs intermittent intravenous infusion of β-lactam antibiotics for patients with sepsis: a systematic review of randomized clinical trials with meta-analysis and trial sequential analysis

in: Annals of Intensive Care | 2023

von Xiaoming Li | Yi Long | Guixin Wu | +4

9

The Outcome of Discontinuing Tyrosine Kinase Inhibitors in Advanced Sarcoma Following a Favorable Tumor Response to Antiangiogenics Therapy

enthalten in: Journal of clinical medicine | 2022

von Zhang, Z. | Bao, Q. | Fu, Y. | +7

10

A randomised phase 2 study comparing different dose approaches of induction treatment of regorafenib in previously treated metastatic colorectal cancer patients (REARRANGE trial)

enthalten in: European journal of cancer (Oxford, England : 1990) | 2022

von Argilés, G. | Mulet, N. | Valladares-Ayerbes, M. | +58

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[15]